Die diastolische Herzinsuffizienz - eine Erkrankung des Älteren

30 - 50 % der Patienten mit typischen Symptomen der Herzinsuffizienz weisen eine normale oder nur geringgradig reduzierte linksventrikuläre Ejektionsfraktion auf [36] [43]. Überwiegend ist bei ihnen von einer diastolischen Funktionsstörung als Ursache der Herzinsuffizienz auszugehen [32]. Die meisten Patienten mit normaler linksventrikulärer Ejektionsfraktion, bei denen sich eine Herzinsuffizienz entwickelt, sind ältere Frauen [19]. Heute ist die chronische Herzinsuffizienz bereits die häufigste Ursache einer Hospitalisierung bei über 65-Jährigen [25]. In Anbetracht der zu erwartenden Altersentwicklung und der stagnierenden Inzidenz der chronischen Herzinsuffizienz bei gleichbleibend schlechter Prognose im höheren Alter [34] dürfte die diastolischen Herzinsuffizienz zukünftig noch erheblich an Bedeutung gewinnen.

Literatur

• 1 Appleton C P, Hatle L K, Popp R L. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study.  J Am Coll Cardiol. 1988;  12 426-440
• 2 Aronow W S, Kronzon I. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction.  Am J Cardiol. 1993;  71 602-604
• 3 Aurigemma G P, Gaasch W H. Clinical practice. Diastolic heart failure.  N Engl J Med. 2004;  351 1097-1105
• 4 Banerjee P, Banerjee T, Khand A, Clark A L, Cleland J G. Diastolic heart failure: neglected or misdiagnosed?.  J Am Coll Cardiol. 2002;  39 138-141
• 5 Blomstrand P, Kongstad O, Broqvist M, Dahlstrom U, Wranne B. Assessment of left ventricular diastolic function from mitral annulus motion, a comparison with pulsed Doppler measurements in patients with heart failure.  Clin Physiol. 1996;  16 483-493
• 6 Brutsaert D L, Sys S U, Gillebert T C. Diastolic failure: pathophysiology and therapeutic implications.  J Am Coll Cardiol. 1993;  22 318-325
• 7 Caruana L, Petrie M C, Davie A P, McMurray J J. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from „diastolic heart failure” or from misdiagnosis? A prospective descriptive study.  Brit Med J. 2000;  321 215-8
• 8 Cleland J G, Tendera M, Adamus J, Freemantle N, Gray C S, Lye M, O’Mahony D, Polonski L, Taylor J. Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators.  Eur J Heart Fail. 1999;  1 211-217
• 9 Dahlof B. et al . Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.  Lancet. 2002;  359 995-1003
• 10 European Study Group on Diastolic Heart Failure . How to diagnose diastolic heart failure.  Eur Heart J. 1998;  19 990-1003
• 11 Gottdiener J S, McClelland R L, Marshall R, Shemanski L, Furberg C D, Kitzman D W, Cushman M, Polak J, Gardin J M, Gersh B J, Aurigemma G P, Manolio T A. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study.  Ann Intern Med. 2002;  137 631-639
• 12 Hazzard W R. Biological basis of the sex differential in longevity.  J Am Geriatr Soc. 1986;  34 455-471
• 13 Hettwer S PB, Werdan K, Witthaut R. N-terminal pro brain natriuretic peptide detects diastolic dysfunction in symptomatic patients - comparison to tissue doppler imaging.  Eur J Heart Fail. 2004;  68 (Suppl 3)
• 14 Hundley W G, Kitzman D W, Morgan T M, Hamilton C A, Darty S N, Stewart K P, Herrington D M, Link K M, Little W C. Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance.  J Am Coll Cardiol. 2001;  38 796-802
• 15 Hunt S A. et al . ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary.  Circulation. 2001;  104 2996-3007
• 16 Hunt S A. et al . ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary.  J Am Coll Cardiol. 2001;  38 2101-2113
• 17 Jensen J L, Williams F E, Beilby B J, Johnson B L, Miller L K, Ginter T L, Tomaselli-Martin G, Appleton C P. Feasibility of obtaining pulmonary venous flow velocity in cardiac patients using transthoracic pulsed wave Doppler technique.  J Am Soc Echocardiogr. 1997;  10 60-66
• 18 Kass D A. Age-related changes in venticular-arterial coupling: pathophysiologic implications.  Heart Fail Rev. 2002;  7 51-62
• 19 Klapholz M. et al . Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry.  J Am Coll Cardiol. 2004;  43 1432-1438
• 20 Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel A S. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings.  Circulation. 2002;  105 595-601
• 21 Maisel A S. et al . Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.  N Engl J Med. 2002;  347 161-167
• 22 Maisel A S. et al . Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.  J Am Coll Cardiol. 2003;  41 2010-2017
• 23 Mandinov L, Eberli F R, Seiler C, Hess O M. Diastolic heart failure.  Cardiovasc Res. 2000;  45 813-825S>
• 24 Mathew S T, Gottdiener J S, Kitzman D, Aurigemma G. Congestive heart failure in the elderly: the Cardiovascular Health Study.  Am J Geriatr Cardiol. 2004;  13 61-68
• 25 McCullough P A, Philbin E F, Spertus J A, Kaatz S, Sandberg K R, Weaver W D. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study.  J Am Coll Cardiol. 2002;  39 60-69
• 26 McDonagh T A, Robb S D, Murdoch D R, Morton J J, Ford I, Morrison C E, Tunstall-Pedoe H, McMurray J J, Dargie H J. Biochemical detection of left-ventricular systolic dysfunction.  Lancet. 1998;  351 9-13
• 27 McMurray J, Ostergren J, Pfeffer M, Swedberg K, Granger C, Yusuf S, Held P, Michelson E, Olofsson B. Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure.  Eur J Heart Fail. 2003;  5 261-270
• 28 Morrison L K, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea.  J Am Coll Cardiol. 2002;  39 202-209
• 29 Pernenkil R, Vinson J M, Shah A S, Beckham V, Wittenberg C, Rich M W. Course and prognosis in patients > or = 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction.  Am J Cardiol. 1997;  79 216-219
• 30 Philbin E F, Rocco T A, Lindenmuth N W, Ulrich K, Jenkins P L. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors.  Am J Med. 2000;  109 605-613
• 31 Rakowski H. et al . Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography.  J Am Soc Echocardiogr. 1996;  9 736-760
• 32 Redfield M M, Jacobsen S J, Burnett J C, Mahoney D W, Bailey K R, Rodeheffer R J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.  J Am Med Assoc. 2003;  289 194-202
• 33 Redfield M M, Rodeheffer R J, Jacobsen S J, Mahoney D W, Bailey K R, Burnett J C. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study.  Circulation. 2004;  109 3176-3181
• 34 Roger V L, Weston S A, Redfield M M, Hellermann-Homan J P, Killian J, Yawn B P, Jacobsen S J. Trends in heart failure incidence and survival in a community-based population.  J Am Med Assoc. 2004;  292 344-350
• 35 Sanderson J E. Re: The PEP-CHF study.  Eur J Heart Fail. 2000;  2 117
• 36 Senni M, Tribouilloy C M, Rodeheffer R J, Jacobsen S J, Evans J M, Bailey K R, Redfield M M. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.  Circulation. 1998;  98 2282-2289
• 37 Setaro J F, Zaret B L, Schulman D S, Black H R, Soufer R. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance.  Am J Cardiol. 1990;  66 981-986
• 38 Sohn D W. et al . Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function.  J Am Coll Cardiol. 1997;  30 474-480
• 39 Soufer R, Wohlgelernter D, Vita N A, Amuchestegui M, Sostman H D, Berger H J, Zaret B L. Intact systolic left ventricular function in clinical congestive heart failure.  Am J Cardiol. 1985;  55 1032-1036
• 40 Taffet G E, Teasdale T A, Bleyer A J, Kutka N J, Luchi R J. Survival of elderly men with congestive heart failure.  Age Ageing. 1992;  21 49-55
• 41 Takatsuji H, Mikami T, Urasawa K, Teranishi J, Onozuka H, Takagi C, Makita Y, Matsuo H, Kusuoka H, Kitabatake A. A new approach for evaluation of left ventricular diastolic function: spatial and temporal analysis of left ventricular filling flow propagation by color M-mode Doppler echocardiography.  J Am Coll Cardiol. 1996;  27 365-371
• 42 Vasan R S, Benjamin E J, Larson M G, Leip E P, Wang T J, Wilson P W, Levy D. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.  Jama. 2002;  288 1252-1259
• 43 Vasan R S, Larson M G, Benjamin E J, Evans J C, Reiss C K, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.  J Am Coll Cardiol. 1999;  33 1948-1955
• 44 Vasan R S, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria.  Circulation. 2000;  101 2118-2121
• 45 Warner J G, Metzger D C, Kitzman D W, Wesley D J, Little W C. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise.  J Am Coll Cardiol. 1999;  33 1567-1572
• 46 Yamaguchi H, Yoshida J, Yamamoto K, Sakata Y, Mano T, Akehi N, Hori M, Lim Y J, Mishima M, Masuyama T. Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy.  J Am Coll Cardiol. 2004;  43 55-60
• 47 Yamamoto K, Burnett J C, Jougasaki M, Nishimura R A, Bailey K R, Saito Y, Nakao K, Redfield M M. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.  Hypertension. 1996;  28 988-994
• 48 Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.  N Engl J Med. 2000;  342 145-153
• 49 Zile M R, Brutsaert D L. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function.  Circulation. 2002;  105 1387-1393
• 50 Zile M R, Gaasch W H, Carroll J D, Feldman M D, Aurigemma G P, Schaer G L, Ghali J K, Liebson P R. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?.  Circulation. 2001;  104 779-782